Tagworks Pharmaceuticals Announces $65 Million in Series A Financing to Advance Click-to-Release Therapeutics
The financing will support the advancement of TGW101, Tagworks' lead click-cleavable ADC program, and the company's proprietary Click-to-Release platform.